***Zika virus (Shorts and Longs) (ZIKA)***

[GhostInTheMatrix]

$GNBT HUGE DD: HEMA DIAGNOSTIC SYSTEMS Announces the Execution of A Non-Binding Letter Of Intent with Generex Biotechnology Corporation.

MIRAMAR, FL / October 1, 2015 / Hema Diagnostic Systems, LLC (HDS), a leading U.S. manufacturer of in-vitro, point-of-care medical devices for infectious diseases, announced today the execution of a non-binding letter of intent (LOI) with Generex Biotechnology Corporation (Generex) (www.generex.com) (GNBT) whereby Generex will acquire a 51% equity interest in HDS in exchange for a purchase price of $15,000,000.

As HDS has been in the world markets for many years, it has developed relationships in many countries throughout Africa, South and Central America, Eastern Europe and into the Arab Gulf. These relationships, many of which are direct with health ministries, open certain doors for us.

HDS is also an approved vendor under UNESCO, UNICEF, UNPD and Aramco.

The current HDS product line includes rapid tests for HIV, Malaria, Syphilis, Hepatitis-B, Hepatitis-C and Tuberculosis. Products under development include Dengue IgG/IgM, Dengue NS1, Ebola and Anthrax (LF/PA).

http://finance.yahoo.com/news/hema-diagnostic-systems-discussions-equity-164300843.html